Aggarwal Gaurav
- SEC CIK
- 0001551965
No open-market purchases or sales filed in the past year.
Current role at each company
- UNCY Unicycive Therapeutics, Inc.Directoras of Aug 26, 2025
- GERN Geron CorpDirectoras of May 22, 2025
- SRRA Sierra Oncology, Inc.Directoras of Jul 1, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Aggarwal Gaurav as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
SRRA Sierra Oncology, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 (view filing) | Jan 31 | Same day | Aggarwal GauravDirector, 10% Owner | PPurchase | +800.0K | $27.00 | +$21.6M | +41.3%2.74M after |